一、行情回顾 沪指全天震荡上扬，录得13连阳走势，刷新十年多以来新高，市场热点轮番活跃。脑机接口概念延续涨势，三博脑科、创新医疗等多股涨停。券商、保险等 金融股拉升，华安证券、华林证券涨停。有色板块走强，洛阳钼业、紫金矿业等多股创历史新高。商业航天继续活跃，北斗星通、中国卫通6天4板。个股涨 多跌少，沪深京三市约4100股飘红，连续两日超百股涨停，今日成交2.83万亿。 | 普利特 | 2天2板 | | +10.01% | | 3.49% | | I、公円 □ヨ荷 ｿ 行了共同开发以及 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002324.SZ | | 19.35 | | 09:25:00 | | 150.21亿 | 顺利; 2、公司L( | | | | | | | | | 卫星等商业航天领 | | 国际医学 | 2天2板 | 5.19 | +9.96% | 09:25:00 | 2.16% | 114.43亿 | 公司旗下医疗机构 | | 000516.SZ | | | | | | | | | | | | | | | | 全资子公司岩思类 ...

从资金流向上来看，当日医疗服务板块主力资金净流出4028.92万元，游资资金净流出1.62亿元，散户资 金净流入2.02亿元。医疗服务板块个股资金流向见下表： | 代码 | 名称 | 主力净流入 (元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603259 | 药明康德 | 1.80 Z | 4.07% | 1.01亿 | 2.28% | -2.81 Z | -6.35% | | 301293 | 三博脑科 | 9474.34万 | 31.32% | -5881.76万 | -19.44% | -3592.59万 | -11.88% | | 002173 | 创新医疗 | 7708.81万 | 56.37% | -3382.60万 | -24.74% | -4326.21万 | -31.64% | | 300015 | 爱尔眼科 | 7521.51万 | 7.12% | -1571.23万 | -1.49% | -5950.28万 | -5.63% ...

Market Performance - The A-share and Hong Kong stock markets continued their "opening red" trend, with the Shanghai Composite Index achieving a rare 13 consecutive days of gains, setting a record and reaching a new high in over 10 years [2] - The total market turnover in the Shanghai and Shenzhen stock exchanges reached 2.83 trillion yuan, marking a new high in over three months [2] - The Hang Seng Index and other indices rose over 1%, with the financial sector leading the gains, particularly Chinese brokerage firms [4][5] Sector Highlights - The commercial aerospace sector saw significant gains, with multiple stocks hitting the daily limit, driven by favorable developments such as the IPO of Blue Arrow Aerospace and accelerated low-orbit satellite launches [2] - The brain-computer interface concept also experienced a surge, with several stocks achieving consecutive gains [2] - The financial sector collectively rose, with stocks like Huayin Securities and Dazhihui hitting the daily limit [3] Precious Metals - Gold and silver prices continued to soar, with silver rising over 3% and gold surpassing 4,460 USD per ounce [6] - Analysts noted that the rise in precious metals is linked to geopolitical events, particularly the situation in Venezuela, and the global competition for key resources in the AI race [7][8]

Market Overview - The Shanghai Composite Index experienced a rare 13 consecutive days of gains, breaking the previous high from November 14, 2025, and reaching a new high since July 2015, closing up by 1.50% [1] - The market saw over 4,100 stocks in the green, with significant contributions from financial sectors such as brokerage, insurance, and internet finance [1] Seasonal Trends - According to Zheshang Securities, the first quarter typically sees a "spring rally," where small and mid-cap growth indices perform best, setting the stage for February's market performance [1] Key Sectors Financial Sector - Major financial stocks like Dazhihui and Hualin Securities hit the daily limit, while China Ping An reached a new five-year high [1] Brain-Computer Interface - The brain-computer interface sector saw a surge, with nearly 20 stocks hitting the daily limit, driven by breakthroughs in clinical trials for a new fully implanted device [3] - The industry is expected to enter a critical phase of large-scale application, supported by policy backing and ongoing technological advancements [3] Non-Ferrous Metals - The non-ferrous metals sector strengthened, with companies like Luoyang Molybdenum and Zijin Mining reaching historical highs, influenced by rising global metal prices [4] - The London Metal Exchange reported significant price increases for tin and copper, indicating strong demand and supply dynamics [4] Solid-State Batteries - The solid-state battery sector experienced a rally, with several stocks hitting the daily limit, following the announcement of a commercially viable solid-state battery by Donut Lab [5] - The sector is expected to progress towards industrialization, supported by policy focus and active participation from industry players [5] Semiconductor Sector - The semiconductor sector remained active, with storage chips and semiconductor equipment leading the gains, as companies like Beifang Huachuang reached historical highs [6] - Price increases for DRAM chips were reported, with significant hikes expected in Q1 2026 [7] Institutional Insights - Guotai Junan Securities highlighted the internal trend of a "transformation bull market" in China, driven by economic shifts and capital market reforms [8] - Debon Securities expressed optimism for a slow bull market following the New Year, with expectations for continued upward movement in the A-share market [8] - Dongfang Securities noted that the market's upward trend is supported by strong investor confidence and the commercialization of new industries like brain-computer interfaces and AI [9]

Group 1 - The core focus of the news is the explosive growth of the brain-computer interface (BCI) sector in the A-share market, with significant stock price increases observed on the first trading day of 2026, particularly for companies involved in BCI technology [1][5] - Notable stock performances include BeiYikang with a 30% increase, and other companies like Sanbo Brain Science, Xiangyu Medical, and Meihai Medical all achieving around 20% gains [1][5] - The surge in the BCI sector is attributed to three major developments: Neuralink's announcement of large-scale production of BCI devices, the implementation of new industry standards in China, and successful clinical trials demonstrating the technology's effectiveness [3][4][6] Group 2 - Neuralink, led by Elon Musk, announced that its BCI devices will enter mass production in 2026, along with a breakthrough in automated surgical technology for implanting devices [3] - A new industry standard for BCI medical devices in China, effective January 1, 2026, aims to provide regulatory clarity and facilitate clinical trials and product approvals [4] - A successful human trial in China demonstrated the ability to restore movement in paralyzed patients using implanted electrodes, showcasing rapid advancements in BCI technology [6] Group 3 - Investment interest in the BCI sector is heightened, with major international banks like Goldman Sachs, BNP Paribas, and Morgan Stanley focusing on companies like Innovation Medical, which has a strategic advantage due to its hospital resources [8] - The global BCI market is projected to reach $12.4 billion by 2034, with a compound annual growth rate of 17% from 2025 to 2034, indicating strong long-term growth potential [9] - The potential applications of BCI technology are expanding beyond medical uses, with possibilities in consumer electronics and smart home integration, suggesting a broader market impact [11] Group 4 - Despite the excitement, challenges remain in ensuring the long-term viability of implanted electrodes and improving the accuracy of non-invasive BCI systems [12] - Following the stock price surge, regulatory bodies have issued inquiries to several companies in the BCI sector to ensure transparency regarding their business operations and R&D progress [12] - Innovation Medical's stock has seen significant increases, but analysts caution that its current valuation is high, and investors should monitor the actual progress of its BCI projects and their impact on profitability [14]

创新医疗、倍益康、三博脑科、南京熊猫、美好医疗涨停，熵基科技涨超15%，麦澜德、爱朋医疗涨超 10%。 (本文来自第一财经) ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The brain-computer interface (BCI) technology is undergoing a period of accelerated transformation, with various technical paths available, including invasive, semi-invasive, and non-invasive methods, each with its own advantages in signal quality, safety, and operational difficulty [5][19] - The Chinese brain-computer interface market is projected to grow significantly, with the market size reaching approximately 1.73 billion yuan in 2023, accounting for 12.5% of the global market [6] - The industry is supported by a three-pronged policy approach focusing on planning, payment, and standards, which is expected to facilitate rapid development [6][33] Summary by Sections 1. Brain-Computer Interface Overview - BCI is a multidisciplinary technology that integrates neuroscience, computer science, and engineering to enable communication between the brain and external devices [17] - The technology operates through a closed-loop system involving signal input, processing, device control, and feedback [17] 2. Policy Support for BCI Development - The Chinese government has issued several policies to support the BCI industry, including the "Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry" which outlines goals for 2027 and 2030 [6][43] - The policies aim to establish a robust industrial ecosystem, enhance innovation capabilities, and promote clinical applications of BCI technologies [43][44] 3. Technological Advancements and Applications - Core technological breakthroughs are occurring in the upstream segment of the BCI industry, particularly in hardware such as electrodes and chips [7] - The medical application of BCI is predominant, with 56% of the market share in 2023, focusing on various therapeutic areas including cognitive disorders and movement disabilities [7][9] - Companies like Lepu Medical and Aipeng Medical are actively involved in developing deep brain stimulation (DBS) technologies, with some preparing for IPOs [7][8] 4. Investment Recommendations - The report suggests focusing on both invasive and non-invasive BCI products, with specific companies identified as beneficiaries based on their clinical trial progress and commercialization potential [8] - Notable companies include Aipeng Medical and Lepu Medical for invasive products, and Xiangyu Medical and Innovation Medical for non-invasive products [8]

Market Performance - The Shanghai Composite Index reached a new high since July 3, 2015, at 4061.12 points on January 6, with overall market trading activity being robust, as the combined trading volume of the Shanghai and Shenzhen markets exceeded 1 trillion yuan shortly after 10 AM [1] Sector Performance - The metal, insurance, and brokerage sectors showed significant gains, with Huayin Securities (002945) hitting the daily limit, and Huashan Securities (600909) rising over 9%. Other securities firms such as Northeast Securities, Huatai Securities, and Caida Securities also experienced upward movement [1] Concept Trends - The brain-computer interface concept continued its strong performance from the previous day, with related indices rising over 4%. Stocks like Aipeng Medical (300753), Xiangyu Medical, Meihao Medical (301363), and Innovation Medical (002173) reached their daily limits [3] - According to a report by Open Source Securities, the brain-computer interface industry is in a high-growth phase driven by technological breakthroughs, policy support, and expectations of robotic ecosystem collaboration [3] Solid-State Battery Developments - On January 5, Finnish electric mobility technology company Donut Lab announced it would debut the world's first commercially viable solid-state battery at the 2026 CES, emphasizing that it is now ready for production [3] - Guangfa Securities noted that solid-state batteries have entered the pilot production stage, with equipment manufacturers benefiting from industrial breakthroughs, and some companies have already shipped related equipment and are collaborating with downstream clients for process validation [3]

Market Overview - The Shanghai Composite Index closed at 4069.38 points, up 1.14%, while the Shenzhen Component Index closed at 13940.24 points, up 0.81%. The ChiNext Index fell by 0.04%, and the Sci-Tech 50 Index rose by 1.95% [1]. Stock Performance - Among the tradable A-shares, 3463 stocks rose, accounting for 66.96%, while 1540 stocks fell, and 169 stocks remained flat. There were 106 stocks that hit the daily limit up, and 2 stocks hit the limit down [1]. - The sectors with the most stocks hitting the limit up included basic chemicals (13 stocks), machinery (12 stocks), and pharmaceuticals (11 stocks) [1]. Notable Stocks - **Yanshan Technology (002195)**: Closed at 8.58 CNY with a trading volume of 42,309.59 thousand shares and a total fund of 363.02 million CNY [1]. - **Fenglong Shares (002931)**: Closed at 38.36 CNY with a trading volume of 5,537.02 thousand shares and a total fund of 21.24 million CNY [1]. - **Innovative Medical (002173)**: Closed at 26.03 CNY with a trading volume of 7,616.63 thousand shares and a total fund of 198.26 million CNY [1]. - **Shan Zi Gao Ke (000981)**: Closed at 4.46 CNY with a trading volume of 32,067.58 thousand shares and a total fund of 143.02 million CNY [1]. ST Stocks - Among the stocks hitting the limit up, 19 were ST stocks, including *ST Yangguang and *ST Wanfang [1]. - **Sheng Tong Energy (001331)**: Closed at 50.94 CNY with a trading volume of 358.76 thousand shares and a total fund of 18.28 million CNY [2]. Sector Highlights - The basic chemicals sector showed strong performance with multiple stocks hitting the limit up, indicating potential investor interest [1]. - The machinery and medical sectors also had significant representation among the top gainers, suggesting a favorable market sentiment towards these industries [1].

非银金融板块盘中快速拉升，其中被视为"牛市旗手"或"市场风向标"的券商股强劲上行，华林证券（002945）冲上涨停，华安证券（600909）、东北证券 等多股大涨。 | < ロ | 券商指数(886054) 11968.03 392.47 +3.39% | | | O | | --- | --- | --- | --- | --- | | 资料 | 资讯 成分 | | 相关基金 | 月度收益 | | 华林证券 | | 17.84 | 9.99% | 0.00% | | 002945.SZ | | | | | | 华安证券 | | 7.58 | 9.70% | -0.26% | | 600909.SH | | | | | 1月6日，沪指高开高走，截至午盘收盘，沪指涨1.14%，创十年新高。深成指涨0.81%，创业板指跌0.04%。沪深两市半日成交额1.8万亿，较上个交易日放 量1455亿，全市场近3700只个股上涨。 | 上证指数 | 深证成指 | 科创综指 | | --- | --- | --- | | 4069.38 | 13940.24 | 1713.58 | | +45.96 +1.14% +111.6 ...